Article

Enhanced risk stratification in early-stage endometrial cancer: Integrating Molucular-L1CAM Classification and Simplified L1CAM/p53 Categorization

2023-08-11

Abstract excerpt

<h4>Aim: </h4> To improve risk stratification in early-stage endometrial cancer (EC), we performed mo-lecular classification, and L1CAM immunohistochemistry (IHC) for additional risk assessment. <h4>Method:</h4> We analyzed archival tumor tissue from 247 early-stage EC patients. POLE mutations were detected using a Droplet digital polymerase chain reaction assay and Sanger sequencing, while the mismatch repair (MM...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d440d446-e536-585b-976d-6b5a2608d61d
DOI: 10.20944/preprints202308.0879.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Enhanced risk stratification in early-stage endometrial cancer: Integrating Molucular-L1CAM Classification and Simplified L1CAM/p53 CategorizationDOI 10.20944/preprints202308.0879.v1Read

Enhanced Risk Stratification in Early-Stage Endometrial Cancer: Integrating POLE through Droplet Digital PCR and L1CAMSemantic proximity Read

The prognosis of endometrial cancers stratified with conventional risk factors and modified molecular classificationSemantic proximity Read

Prognostic and therapeutic implication of molecular classification including L1CAM expression in high-risk endometrial cancer.Semantic proximity Read

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practiceSemantic proximity Read

Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancer.Semantic proximity Read

Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments.Semantic proximity Read

Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.Semantic proximity Read

Molecular Characterization and Clinical Implications of Endometrial Cancer.Semantic proximity Read

Associations between molecular subtypes and high-risk pathological factors in endometrial cancer.Semantic proximity Read

Molecular Classification of Endometrial Cancer of Chinese PopulationSemantic proximity Read

Association of Molecular Classification with FIGO Stage and Survival Outcomes in Endometrial Cancer.Semantic proximity Read

The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment DecisionsSemantic proximity Read